Similarly, amplification of the PDZK1 gene within the chr 1q12-q22 region has been observed in primary cases of MM, and the overexpression of PDZK1 in cells conferred resistance to melphalan-, vincristine-, and cisplatin-induced cell deaths (115) (Table 1). The gene discussed is PDZK1; the disease is Miyoshi myopathy.